BluePath Capital Management
ABBV icon

BluePath Capital Management’s AbbVie ABBV Stock Holding History

BluePath Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.7M Buy
6,510
+277
+4% +$71K 0.89% 33
2026
Q2 		$1.57M Buy
6,233
+351
+6% +$75.5K 0.86% 28
2026
Q1 		$1.28M Buy
5,882
+591
+11% +$131K 0.88% 32
2025
Q4 		$1.21M Buy
5,291
+547
+12% +$125K 0.82% 35
2025
Q3 		$1.1M Sell
4,744
-3,749
-44% -$763K 0.8% 47
2025
Q2 		$1.58M Buy
8,493
+1,385
+19% +$257K 1.39% 14
2025
Q1 		$1.49M Sell
7,108
-4,050
-36% -$787K 1.55% 11
2024
Q4 		$1.97M Buy
11,158
+1,902
+21% +$350K 1.06% 19
2024
Q3 		$1.83M Buy
9,256
+30
+0.3% +$5.6K 1.13% 19
2024
Q2 		$1.58M Buy
9,226
+1,915
+26% +$317K 1.11% 17
2024
Q1 		$1.33M Buy
7,311
+67
+0.9% +$11.5K 1% 17
2023
Q4 		$1.19M Buy
7,244
+1,051
+17% +$153K 1.02% 16
2023
Q3 		$923K Buy
+6,193
New +$909K 0.85% 17

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

BluePath Capital Management's ABBV Position: Q3 2026 in Review

BluePath Capital Management increased its AbbVie (ABBV) stake by 4.4% in Q3 2026, buying an estimated $71K and bringing the position to 6,510 shares worth $1.7M. The position accounts for 0.89% of the portfolio, ranked #33.

BluePath Capital Management first reported a position in ABBV in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.97M in Q4 2024. 1,712 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • BluePath Capital Management held 6,510 shares of AbbVie worth $1.7M as of Q3 2026.
  • BluePath Capital Management bought 277 AbbVie shares in Q3 2026, an estimated $71K.
  • AbbVie made up 0.89% of BluePath Capital Management's portfolio in Q3 2026, its #33 holding.
  • BluePath Capital Management first reported a position in AbbVie in Q3 2023 and has held it in 13 quarters since.
  • BluePath Capital Management's AbbVie position peaked at $1.97M in Q4 2024.
  • 1,712 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on BluePath Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.